1. Potential drug targets in the Mycobacterium tuberculosis cytochrome P450 system.
- Author
-
Ortiz de Montellano PR
- Subjects
- Azoles pharmacology, Catalysis, Crystallography, X-Ray, Cytochrome P-450 Enzyme System chemistry, Cytochrome P-450 Enzyme System metabolism, Drug Discovery, Mycobacterium smegmatis drug effects, Mycobacterium smegmatis enzymology, Mycobacterium tuberculosis enzymology, Protein Conformation, Antitubercular Agents pharmacology, Cytochrome P-450 Enzyme Inhibitors pharmacology, Cytochrome P-450 Enzyme System drug effects, Mycobacterium tuberculosis drug effects
- Abstract
The Mycobacterium tuberculosis genome encodes twenty cytochrome P450 enzymes, most or all of which appear to have specific physiological functions rather than being devoted to the removal of xenobiotics. However, in many cases their specific functions remain obscure. Considerable spectroscopic, biophysical, crystallographic, and catalytic information is available on nine of these cytochrome P450 enzymes, although gaps exist in our knowledge of even these enzymes. The available evidence indicates that at least three of the better-characterized enzymes are promising targets for antituberculosis drug discovery. This review summarizes the information on the nine relatively well-characterized cytochrome P450 enzymes, with a particular emphasis on CYP121, CYP125, and CYP142 from Mycobacterium tuberculosis and Mycobacterium smegmatis., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF